CLINICAL_TRIALS
trial_result
· 2012-02-08
Clinical Trial Update: Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Summary
A completed Phase 2 study evaluating forodesine hydrochloride in patients with advanced, fludarabine-refractory chronic lymphocytic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BioCryst Pharmaceuticals | Conditions: Leukemia, Lymphocytic, Chronic | Phase 2 | Status: COMPLETED